Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High‐content drug screening for rare diseases
Francesco Bellomo, Diego L. Medina, Ester De Leo, et al.
Journal of Inherited Metabolic Disease (2017) Vol. 40, Iss. 4, pp. 601-607
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

The rapidly evolving view of lysosomal storage diseases
Giancarlo Parenti, Diego L. Medina, Andrea Ballabio
EMBO Molecular Medicine (2021) Vol. 13, Iss. 2
Open Access | Times Cited: 174
Current methods to analyze lysosome morphology, positioning, motility and function
Duarte C. Barral, Leopoldo Staiano, Cláudia G. Almeida, et al.
Traffic (2022) Vol. 23, Iss. 5, pp. 238-269
Open Access | Times Cited: 86
Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives
Angelo Giuseppe Condorelli, Elena Dellambra, E. Logli, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5707-5707
Open Access | Times Cited: 105
Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis
Ester De Leo, Mohamed A. Elmonem, Sante Princiero Berlingerio, et al.
Journal of the American Society of Nephrology (2020) Vol. 31, Iss. 7, pp. 1522-1537
Open Access | Times Cited: 40
Object detection networks and augmented reality for cellular detection in fluorescence microscopy
Dominic Waithe, Jill M. Brown, Katharina Reglinski, et al.
The Journal of Cell Biology (2020) Vol. 219, Iss. 10
Open Access | Times Cited: 35
Antisense oligonucleotides and their applications in rare neurological diseases
Simon McDowall, May T. Aung-Htut, Steve D. Wilton, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
iDrugs andiDevices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants
Najam A. Sharif
Journal of Ocular Pharmacology and Therapeutics (2018) Vol. 34, Iss. 1-2, pp. 7-39
Closed Access | Times Cited: 35
Drug Repositioning: Concept, Classification, Methodology, and Importance in Rare/Orphans and Neglected Diseases
Emanuel Almeida Moreira de Oliveira, Karen Luise Lang
Journal of Applied Pharmaceutical Science (2018), pp. 157-165
Open Access | Times Cited: 33
Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
Helena Montanuy, Águeda Martínez‐Barriocanal, José Antonio Casado, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 12, pp. 3044-3057
Open Access | Times Cited: 30
A new paradigm for drug discovery in the treatment of complex diseases: drug discovery and optimization
Yu Yuan, Lu-Lu Yu, Chenghao Bi, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Mitochondrial Dynamics of Proximal Tubular Epithelial Cells in Nephropathic Cystinosis
Domenico De Rasmo, Anna Signorile, Ester De Leo, et al.
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 192-192
Open Access | Times Cited: 28
Drug Repurposing in Rare Diseases: An Integrative Study of Drug Screening and Transcriptomic Analysis in Nephropathic Cystinosis
Francesco Bellomo, Ester De Leo, Anna Taranta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12829-12829
Open Access | Times Cited: 21
Precision medicine for rare diseases: The times they are A-Changin'
Margarida D. Amaral
Current Opinion in Pharmacology (2022) Vol. 63, pp. 102201-102201
Closed Access | Times Cited: 11
Real-World Synthetic Biology: Is It Founded on an Engineering Approach, and Should It Be?
Jamie A. Davies
Life (2019) Vol. 9, Iss. 1, pp. 6-6
Open Access | Times Cited: 17
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
Maria Kamusheva, Manoela Manova, Alexandra T. Savova, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 16
Development of Orthogonal Linear Separation Analysis (OLSA) to Decompose Drug Effects into Basic Components
Tadahaya Mizuno, Setsuo Kinoshita, Takuya Ito, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders
Alexandra Benchoua, Marie Lasbareilles, Johana Tournois
Cells (2021) Vol. 10, Iss. 12, pp. 3290-3290
Open Access | Times Cited: 10
Defective Cystinosin, Aberrant Autophagy−Endolysosome Pathways, and Storage Disease: Towards Assembling the Puzzle
Laura Rita Rega, Ester De Leo, Daniela Nieri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 326-326
Open Access | Times Cited: 7
Diet and Nutrients in Rare Neurological Disorders: Biological, Biochemical, and Pathophysiological Evidence
Marilena Briglia, Fabio Allia, Rosanna Avola, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3114-3114
Open Access | Times Cited: 1
Pharmacological approaches to tackle NCLs
Valerjans Kauss, Maija Dambrova, Diego L. Medina
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1866, Iss. 9, pp. 165553-165553
Open Access | Times Cited: 10
Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
Liyuan Zhu, Ruth Roberts, Ruili Huang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 9
Construction of a tri-chromatic reporter cell line for the rapid and simple screening of splice-switching oligonucleotides targeting DMD exon 51 using high content screening
Takenori Shimo, Keisuke Tachibana, Satoshi Obika
PLoS ONE (2018) Vol. 13, Iss. 5, pp. e0197373-e0197373
Open Access | Times Cited: 8
Hollow Micropillar Array Method for High-Capacity Drug Screening on Filter-Grown Epithelial Cells
Byung‐Ju Jin, Sujin Lee, A. S. Verkman
Analytical Chemistry (2018) Vol. 90, Iss. 12, pp. 7675-7681
Open Access | Times Cited: 7
Object Detection Networks and Augmented Reality for Cellular Detection in Fluorescence Microscopy Acquisition and Analysis
Dominic Waithe, JM Brown, Katharina Reglinski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 7
High-content screening of Aspergillus niger with both increased production and high secretion rate of glucose oxidase
Xudong Zhu, Jingchun Sun, Ju Chu
Biotechnology Letters (2017) Vol. 40, Iss. 1, pp. 103-110
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top